These findings suggest a link between FOXO3 and its target genes (Atrogin-1 and Murf-1) and therefore the PI3K/AKT pathway to sarcopenia, highlighting FOXO3 as a possible target. This evidence concerns the gene FOXO3 and sarcopenia.